PuSH - Publication Server of Helmholtz Zentrum München

Menditto, E.* ; Costa, E.* ; Midao, L.* ; Bosnic-Anticevich, S.* ; Novellino, E.* ; Bialek, S.* ; Briedis, V.* ; Mair, A.* ; Rajabian-Soderlund, R.* ; Arnavielhe, S.* ; Bedbrook, A.* ; Czarlewski, W.* ; Annesi-Maesano, I.* ; Antò, J.M.* ; Devillier, P.* ; De Vries, G.* ; Keil, T.* ; Sheikh, A.* ; Orlando, V.* ; Larenas-Linnemann, D.* ; Cecchi, L.* ; De Feo, G.* ; Illario, M.* ; Stellato, C.* ; Fonseca, J.* ; Malva, J.* ; Morais-Almeida, M.* ; Pereira, A.M.* ; Todo-Bom, A.M.* ; Kvedariene, V.* ; Valiulis, A.* ; Bergmann, K.C.* ; Klimek, L.* ; Moesges, R.* ; Pfaar, O.* ; Zuberbier, T.* ; Cardona, V.* ; Mullol, J.* ; Papadopoulos, N.G.* ; Prokopakis, E.P.* ; Bewick, M.* ; Ryan, D.* ; Roller-Wirnsberger, R.E.* ; Tomazic, P.V.* ; Cruz, A.A.* ; Kuna, P.* ; Samolinski, B.* ; Fokkens, W.J.* ; Reitsma, S.* ; Bosse, I.* ; Fontaine, J.-F.* ; Laune, D.* ; Haahtela, T.* ; Toppila-Salmi, S.* ; Bachert, C.* ; Hellings, P.W.* ; Melén, E.* ; Wickman, M.* ; Bindslev-Jensen, C.* ; Eller, E.* ; O'Hehir, R.E.* ; Cingi, C.* ; Gemicioğlu, B.* ; Kalayci, O.* ; Ivancevich, J.C.* ; Bousquet, J.* ; MASK Study Group (Darsow, U.)

Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study.

Clin. Exp. Allergy 49, 442-460 (2019)
Postprint DOI PMC
Open Access Green
Background: Mobile technology may help to better understand the adherence to treatment. MASK-rhinitis (Mobile Airways Sentinel NetworK for allergic rhinitis) is a patient-centred ICT system. A mobile phone app (the Allergy Diary) central to MASK is available in 22 countries.Objectives: To assess the adherence to treatment in allergic rhinitis patients using the Allergy Diary App.Methods: An observational cross-sectional study was carried out on all users who filled in the Allergy Diary from 1 January 2016 to 1 August 2017. Secondary adherence was assessed by using the modified Medication Possession Ratio (MPR) and the Proportion of days covered (PDC) approach.Results: A total of 12143 users were registered. A total of 6949 users reported at least one VAS data recording. Among them, 1887 users reported >= 7 VAS data. About 1195 subjects were included in the analysis of adherence. One hundred and thirty-six (11.28%) users were adherent (MPR >= 70% and PDC <= 1.25), 51 (4.23%) were partly adherent (MPR >= 70% and PDC = 1.50) and 176 (14.60%) were switchers. On the other hand, 832 (69.05%) users were non-adherent to medications (MPR <70%). Of those, the largest group was non-adherent to medications and the time interval was increased in 442 (36.68%) users.Conclusion and clinical relevance: Adherence to treatment is low. The relative efficacy of continuous vs on-demand treatment for allergic rhinitis symptoms is still a matter of debate. This study shows an approach for measuring retrospective adherence based on a mobile app. This also represents a novel approach for analysing medication-taking behaviour in a real-world setting.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
4.741
1.415
33
32
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Adherence ; Mhealth ; Mobile Technology ; Observational Study ; Rhinitis ; Treatment; Controller Medication; K-anonymity; Asthma; Persistence; Validation; Therapy; Disease; Trial
Language english
Publication Year 2019
HGF-reported in Year 2019
ISSN (print) / ISBN 0954-7894
e-ISSN 1365-2222
Quellenangaben Volume: 49, Issue: 4, Pages: 442-460 Article Number: , Supplement: ,
Publisher Wiley
Publishing Place 111 River St, Hoboken 07030-5774, Nj Usa
Reviewing status Peer reviewed
POF-Topic(s) 30202 - Environmental Health
Research field(s) Allergy
PSP Element(s) G-505400-001
PubMed ID 30597673
Erfassungsdatum 2019-04-19